BIO-TECHNE Corp Accumulated Other Comprehensive Income
BIO-TECHNE Corp (TECH) had Accumulated Other Comprehensive Income of -$70.58 million as of 2026-06-30, per its 10-K filed 2026-08-24.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-24
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$70.58M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$66.86M.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$62.34M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$64.39M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$70.58M 10-K · filed 2026-08-24 |
| 2026-03-31 | -$66.86M 10-Q · filed 2026-05-06 |
| 2025-12-31 | -$62.34M 10-Q · filed 2026-02-04 |
| 2025-09-30 | -$64.39M 10-Q · filed 2025-11-05 |
| 2025-06-30 | -$59.88M 10-K · filed 2026-08-24 |
| 2025-03-31 | -$82.05M 10-Q · filed 2025-05-08 |
| 2024-12-31 | -$85.65M 10-Q · filed 2025-02-06 |
| 2024-09-30 | -$60.09M 10-Q · filed 2024-11-05 |
| 2024-06-30 | -$78.32M 10-K · filed 2025-08-22 |
| 2024-03-31 | -$75.31M 10-Q · filed 2024-05-06 |
| 2023-12-31 | -$63.66M 10-Q · filed 2024-02-07 |
| 2023-09-30 | -$78.02M 10-Q · filed 2023-11-07 |
| 2023-06-30 | -$66.06M 10-K · filed 2024-08-22 |
| 2023-03-31 | -$73.55M 10-Q · filed 2023-05-08 |
| 2022-12-31 | -$75.13M 10-Q · filed 2023-02-07 |
| 2022-09-30 | -$91.81M 10-Q · filed 2022-11-07 |
| 2022-06-30 | -$75.20M 10-K · filed 2023-08-23 |
| 2022-03-31 | -$55.15M 10-Q · filed 2022-05-09 |
| 2021-12-31 | -$59.47M 10-Q · filed 2022-02-07 |
| 2021-09-30 | -$64.22M 10-Q · filed 2021-11-08 |
| 2021-06-30 | -$57.29M 10-K · filed 2022-08-24 |
| 2021-03-31 | -$64.02M 10-Q · filed 2021-05-07 |
| 2020-12-31 | -$64.24M 10-Q · filed 2021-02-08 |
| 2020-09-30 | -$83.14M 10-Q · filed 2020-11-09 |
| 2020-06-30 | -$97.20M 10-K · filed 2021-08-25 |
| 2020-03-31 | -$103.46M 10-Q · filed 2020-05-11 |
| 2019-12-31 | -$78.35M 10-Q · filed 2020-02-06 |
| 2019-09-30 | -$91.63M 10-Q · filed 2019-11-06 |
| 2019-06-30 | -$83.52M 10-K · filed 2020-08-26 |
| 2019-03-31 | -$79.63M 10-Q · filed 2019-05-07 |
| 2018-12-31 | -$83.01M 10-Q · filed 2019-02-07 |
| 2018-09-30 | -$70.63M 10-Q · filed 2018-11-07 |
| 2018-06-30 | -$44.81M 10-K/A · filed 2019-11-06 |
| 2018-03-31 | -$15.86M 10-Q · filed 2018-05-09 |
| 2017-12-31 | -$56.82M 10-Q · filed 2018-02-08 |
| 2017-09-30 | -$49.76M 10-Q · filed 2017-11-09 |
| 2017-06-30 | -$48.94M 10-K · filed 2018-08-27 |
| 2017-03-31 | -$65.29M 10-Q · filed 2017-05-10 |
| 2016-12-31 | -$67.22M 10-Q · filed 2017-02-09 |
| 2016-09-30 | -$63.92M 10-Q · filed 2016-11-09 |
| 2016-06-30 | -$70.41M 10-K · filed 2017-09-07 |
| 2016-03-31 | -$76.48M 10-Q · filed 2016-05-10 |
| 2015-12-31 | -$51.53M 10-Q · filed 2016-02-09 |
| 2015-09-30 | -$53.62M 10-Q · filed 2015-11-09 |
| 2015-06-30 | -$30.59M 10-K · filed 2016-08-29 |
| 2015-03-31 | -$41.62M 10-Q · filed 2015-05-11 |
| 2014-12-31 | -$24.48M 10-Q · filed 2015-02-09 |
| 2014-09-30 | -$22.98M 10-Q · filed 2014-11-10 |
| 2014-06-30 | -$5.39M 10-K · filed 2015-08-31 |
| 2014-03-31 | -$3.91M 10-Q · filed 2014-05-12 |
| 2013-12-31 | -$9.95M 10-Q · filed 2014-02-04 |
| 2013-09-30 | -$14.32M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $14.55M 10-K · filed 2014-08-29 |
| 2013-03-31 | $12.84M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $10.25M 10-Q · filed 2013-02-11 |
| 2012-09-30 | $12.14M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $21.77M 10-K · filed 2013-08-29 |
| 2012-03-31 | $6.88M 10-Q · filed 2012-05-10 |
| 2011-12-31 | -$20.90M 10-Q · filed 2012-02-07 |
| 2011-09-30 | -$20.22M 10-Q · filed 2011-11-09 |
| 2011-06-30 | -$16.29M 10-K · filed 2013-08-29 |
| 2011-03-31 | -$15.84M 10-Q · filed 2011-05-10 |
| 2010-12-31 | -$19.05M 10-Q · filed 2011-02-09 |
| 2010-09-30 | -$17.29M 10-Q · filed 2010-11-09 |
| 2010-06-30 | -$21.23M 10-K · filed 2012-08-29 |
| 2009-06-30 | -$7.48M 10-K · filed 2011-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |